The cultivation, production and manufacture of medicinal cannabis drugs has been legal in Australia for over a year.
Recently, the federal government announced its intent to allow exports of Medicinal Cannabis in the future, however there is currently no framework to support this at this stage in time. Regulations are yet to change – especially the Narcotic Drugs Regulation 2016.
While the regulatory terrain is still shifting, here’s what you need to know, how to comply, and how we can help you:
From October 2016, the Australian Office of Drug Control (ODC) began processing license applications for the cultivation, production and manufacturing of medicinal cannabis. Australia has a well established opioid industry and the regulators are rightfully careful to control the access to cannabis so that it is utilised solely for medical purposes.
The main focus of the Australian ODC licence application is an assessment of the control over the crop, as well as people. This is to ensure that no vulnerable communities are at risk and that no unauthorised people are able to access the plants.
Our pharmaceutical architects and engineers have extensive experience in designing a wide variety of pharmaceutical, medical device and complementary medicine manufacturing and distribution facilities.
If you already have a facility design, we can provide an independent Design, ODC, and GMP review to make sure that all the important details are covered and nothing has been missed.